Penumbra's thrombectomy growth and new products show promise, but high valuation at 7x 2025 revenue tempers appeal for GARP ...
Once the intravenous tPA infusion was started, the patient was transferred via air ambulance to a comprehensive stroke center. On arrival (3 h 17 min after symptom onset) the patient remained ...
Penumbra reported Q4 sales of $315.52 million, up 10.8% Y/Y, beating estimates of $311.55 million. U.S. thrombectomy sales jumped 27.3%, driving global growth of 15.4%. Get 5 stock picks ...
But he noted Penumbra didn't offer any insight into its Thunderbolt product. Thunderbolt is in testing for patients with acute ischemic stroke. Thunderbolt "could become a significant growth ...
The MERCI®retrieval device and the Penumbra Stroke System®are US FDA-approved endovascular devices for thrombectomy in acute ischemic stroke due to cerebral vascular occlusions. Widespread ...
Robust improvement of Penumbra, Inc.’s PEN Thrombectomy business ... enormous potential to further expand its leadership in stroke intervention outside the United States with SENDit and ...
Investors in Penumbra, Inc. (NYSE:PEN) had a good week, as its shares rose 8.6% to close at US$292 following the release of its yearly results. It was not a great result overall. While revenues of ...
Penumbra disclaims any duty to update or revise ... Shifting to our neurovascular business. Our U.S. stroke thrombectomy business once again posted strong results with revenue accelerating versus ...
Clinical Outcome in Acute Stroke Treatment After Image Guided Patient Selection for Interventional Revascularization Therapy (START) This industry-sponsored study was designed to assess the safety and ...
1 See "Non-GAAP Financial Measures" for important information about our use of non-GAAP measures. 2 Represents the impact of the Italian government's payback provision pertaining to prior years ...
PENUMBRA ($PEN) is expected to release its quarterly earnings data on Tuesday, February 18th after market close, per Finnhub. Analysts are expecting revenue of ...